KeyBanc Capital Markets has initiated coverage on Rapid Micro Biosystems Inc (NASDAQ:RPID) with an Overweight rating and a price target of $8.00. The new rating comes as KeyBanc analysts recognize the ...
Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback